These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 12190182)

  • 1. Unsaturated iron binding capacity and transferrin saturation are equally reliable in detection of HFE hemochromatosis.
    Murtagh LJ; Whiley M; Wilson S; Tran H; Bassett ML
    Am J Gastroenterol; 2002 Aug; 97(8):2093-9. PubMed ID: 12190182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic screening for HFE hemochromatosis in 6,020 Danish men: penetrance of C282Y, H63D, and S65C variants.
    Pedersen P; Milman N
    Ann Hematol; 2009 Aug; 88(8):775-84. PubMed ID: 19159930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population screening for hemochromatosis: a comparison of unbound iron-binding capacity, transferrin saturation, and C282Y genotyping in 5,211 voluntary blood donors.
    Adams PC; Kertesz AE; McLaren CE; Barr R; Bamford A; Chakrabarti S
    Hepatology; 2000 May; 31(5):1160-4. PubMed ID: 10796893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of hemochromatosis in young subjects: predictive accuracy of biochemical screening tests.
    Bassett ML; Halliday JW; Ferris RA; Powell LW
    Gastroenterology; 1984 Sep; 87(3):628-33. PubMed ID: 6745616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. H63D homozygotes with hyperferritinaemia: Is this genotype, the primary cause of iron overload?
    de Diego C; Opazo S; Murga MJ; Martínez-Castro P
    Eur J Haematol; 2007 Jan; 78(1):66-71. PubMed ID: 17042772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and family studies in genetic hemochromatosis: microsatellite and HFE studies in five atypical families.
    Adams PC; Campion ML; Gandon G; LeGall JY; David V; Jouanolle AM
    Hepatology; 1997 Oct; 26(4):986-90. PubMed ID: 9328324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological variability of transferrin saturation and unsaturated iron-binding capacity.
    Adams PC; Reboussin DM; Press RD; Barton JC; Acton RT; Moses GC; Leiendecker-Foster C; McLaren GD; Dawkins FW; Gordeuk VR; Lovato L; Eckfeldt JH
    Am J Med; 2007 Nov; 120(11):999.e1-7. PubMed ID: 17976429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Searching for hereditary hemochromatosis.
    Laudicina RJ
    Clin Lab Sci; 2006; 19(3):174-83. PubMed ID: 16910235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting C282Y homozygote genotype for hemochromatosis using serum ferritin and transferrin saturation values from 44,809 participants of the HEIRS study.
    Lim A; Speechley M; Adams PC
    Can J Gastroenterol Hepatol; 2014 Oct; 28(9):502-4. PubMed ID: 25314357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for hemochromatosis in asymptomatic subjects with or without a family history.
    Powell LW; Dixon JL; Ramm GA; Purdie DM; Lincoln DJ; Anderson GJ; Subramaniam VN; Hewett DG; Searle JW; Fletcher LM; Crawford DH; Rodgers H; Allen KJ; Cavanaugh JA; Bassett ML
    Arch Intern Med; 2006 Feb; 166(3):294-301. PubMed ID: 16476869
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Sandnes M; Vorland M; Ulvik RJ; Reikvam H
    Genes (Basel); 2021 Jul; 12(8):. PubMed ID: 34440336
    [No Abstract]   [Full Text] [Related]  

  • 12. Is there a threshold of hepatic iron concentration that leads to cirrhosis in C282Y hemochromatosis?
    Adams PC
    Am J Gastroenterol; 2001 Feb; 96(2):567-9. PubMed ID: 11232708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using iron studies to predict HFE mutations in New Zealand: implications for laboratory testing.
    O'Toole R; Romeril K; Bromhead C
    Intern Med J; 2017 Apr; 47(4):447-454. PubMed ID: 28019068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of subjects with abnormal iron studies: role of the hepatic iron index.
    Chapman BA; Horton DM; Burt MJ; Romeril KR; Walmsley TA; Grant SJ; George P
    N Z Med J; 1994 Dec; 107(991):504-7. PubMed ID: 7830980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased urinary excretion of 8-iso-prostaglandin F2alpha in patients with HFE-related hemochromatosis: a case-control study.
    Kom GD; Schwedhelm E; Nielsen P; Böger RH
    Free Radic Biol Med; 2006 Apr; 40(7):1194-200. PubMed ID: 16545687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of genes that may modulate the expression of hereditary hemochromatosis: transferrin receptor-1, ferroportin, ceruloplasmin, ferritin light and heavy chains, iron regulatory proteins (IRP)-1 and -2, and hepcidin.
    Lee PL; Gelbart T; West C; Halloran C; Felitti V; Beutler E
    Blood Cells Mol Dis; 2001; 27(5):783-802. PubMed ID: 11783942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemochromatosis gene mutations, liver function tests and iron status in alcohol-dependent patients admitted for detoxification.
    Robinson G; Narasimhan S; Weatherall M; Beasley R
    J Gastroenterol Hepatol; 2007 Jun; 22(6):852-4. PubMed ID: 17565641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hemochromatosis--from an underdiagnosed curiosity to a common disease].
    Hagve TA; Asberg A; Ulvik R; Borch-Iohnsen B; Thorstensen K
    Tidsskr Nor Laegeforen; 2009 Apr; 129(9):863-6. PubMed ID: 19415085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary hemochromatosis: etiologic, pathologic, and clinical aspects.
    Bothwell TH; MacPhail AP
    Semin Hematol; 1998 Jan; 35(1):55-71. PubMed ID: 9460809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary hemochromatosis: laboratory evaluation.
    Moyer TP; Highsmith WE; Smyrk TC; Gross JB
    Clin Chim Acta; 2011 Aug; 412(17-18):1485-92. PubMed ID: 21510925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.